Open Access

Desmoplastic small round cell tumor: a case report and review of the literature

World Journal of Surgical Oncology201412:9

https://doi.org/10.1186/1477-7819-12-9

Received: 12 September 2013

Accepted: 27 December 2013

Published: 10 January 2014

Abstract

Desmoplastic small round cell tumor is a rare malignant tumor that has a poor prognosis. It affects predominantly young males. In the current report, a 14-year-old male patient was admitted to the hospital for evaluation of abdominal distension, and abdominal pain. Imaging examination revealed a high prevalence of multiple intraperitoneal and liver parenchymal cystic and solid tumors. After an explorative surgery, the pathological findings confirmed the presentation of desmoplastic small round cell tumor. Diagnosis of desmoplastic small round cell tumor could easily have been overlooked since there was no specific evidence for this condition available in the clinical and imaging examinations. In the present study, ultrasound examination detected solid cystic masses, which suggested the presence of necrosis and hemorrhage. Immunohistochemistry and cytogenetic studies confirmed the diagnosis of desmoplastic small round cell tumor in this patient.

Keywords

Desmoplastic small round cell tumorImagingPathology

Background

Desmoplastic small round cell tumor (DSRCT) is a highly malignant small round cell tumor. It was first described by Gerald and Rosai in 1989 and formally named in 1991 [1, 2]. It is frequently prevalent in the abdominal and pelvic cavities of adolescent males with a potential for multidirectional differentiation. The mechanism of histogenesis of this tumor remains unclear but might be derived from multipotential differentiated primitive mesenchymal cells or neuroectodermal and primitive mesenchymal tissue. The ethics committee of the Affiliated Hospital of Qingdao University Medical College, China approved this case study. Informed consent was signed by the recruited patient.

Case presentation

A 14-year-old male patient was admitted to our hospital for evaluation of abdominal distension, and abdominal pain. A physical examination revealed an apparent abdominal mass and tenderness. The mass exhibited an unclear boundary and hard texture. A low degree of mobility was also observed. Ultrasonography (US) of the abdomen revealed multiple cystic-solid masses with regular shape and clear boundaries in the right liver and abdominal cavity with diameters of 12.1 cm to 4.9 cm. In addition, there was a mass in the hilum of the spleen (Figure 1). These findings were confirmed by enhanced computed tomography (CT) of the abdomen (Figure 2).
Figure 1

Ultrasound images of the mass in the right liver and abdominal cavity.

Figure 2

Enhanced CT image in the arterial phase of the mass in the right liver and abdominal cavity.

The DSRCT cell differentiation direction is uncertain, but this tumor can express epithelial, mesenchymal, neuroendocrine, and other immunophenotypes and is cytogenetically specific. In addition, cells can generate the EWS-WT1 fusion gene. DSRCT is a very rare soft tissue tumor.

During the operation, liver segments 5 and 6 that had involved tumor were removed. The portion of the tumor located in hepatic segment 7 was also resected. The hepatic wound was repaired. A mass with a hard texture and nodular surface in the left abdominal cavity was excised. The mass observed in the hilum of the spleen presented with both the splenic artery and vein tightly adhered to the tumor. For this reason, they were completely excised. The pathological findings of the tumor in the abdominal cavity and right hepatic lobe confirmed that the tumor was a multifocal malignant DSRCT. There were multifocal metastatic nodules within the greater omentum. Immunohistochemistry gave the following phenotypic markers: desmin (++), CK (+), Vim (+/-), epithelial membrane antigen.

(EMA) (+/-), CD34 (-), CD117 (-), neuron-specific enolase (NSE) (-), WT-1 (-), and S-100 (-) Figures 3 and 4.
Figure 3

Histological findings of desmoplastic small round cell tumor. A. HE 10×; B. HE 20×.

Figure 4

Immunohistochemistry of desmoplastic small round cell tumor. A. AE1/AE3; B. EMA; C. Desmin; D. Vimtin.

After the operation, it was planned he should receive seven courses of chemotherapy. Up to date, he has already undergone all cycles of chemotherapy and he is in good general condition.

Discussion

DSRCT has the same characteristics as those of other small round cell tumors, such as Ewing's sarcoma, small cell mesothelioma, neuroblastoma, and lymphoma [3]. Thus, it is also classified as an undifferentiated soft tissue tumor [47]. Histologically, DSRCT cells are closely arranged and can form epithelioid cells of varying sizes and shapes. A large involvement of fibrous connective tissue is observed around and among tumor cell nests [3].

In most cases of DSRCT desmin, CK EMA,and vimentin are positive, of which desmin and CK being positive at the same time is considered DSRCT’s most specific immunological indexes. Stromal elements are vimentin positive, prompt from the muscle fiber mother cell.The direction of DSRCT cellular differentiation is largely uncertain. However, this tumor can express epithelial, mesenchymal, neuroendocrine, and other immunophenotypes and is cytogenetically specific. In addition, cells can generate the EWS-WT1 fusion gene [8].

Since it may metastasize to the liver, most commonly, and lungs, and or lymph nodes of the groin,neck, or mediastinum, once abdominal imaging reveals multiple tumors, imaging of the chest with a CT scan and distant metastasis using a total body positron emission tomography (PET) scan, is recommended as the preferred. Percutaneous or open biopsy of the lesion should be evaluated by immunohistochemistry and cytogenetics to confirm the characteristics of DSRCT.

DSRCT mainly occurs in children and adolescents. Primary peritoneal cases account for the vast majority of appearances of this disease, and a few cases are reported in single organs, such as the ovary, lung, kidney, pancreas, bone, and posterior cranial fossa [911]. Clinical manifestations include abdominal distension, abdominal discomfort, abdominal pain, and an abdominal mass accompanied by constipation, dysuria, umbilical hernia, intestinal obstruction, and other compressive symptoms.

Some patients may suffer from acute abdominal discomfort or cannot walk upright because of abdominal pain. The majority of patients develop a reduced body weight compared with that before the onset. Physical examination reveals an apparent mass that is palpable in the abdominal cavity that is accompanied by tenderness, an unclear mass boundary, hard texture, and a low degree of motility. Ultrasound, CT scanning, and magnetic resonance imaging (MRI) often display a large nodular mass within the pelvic or abdominal cavity, mostly in the greater omentum or mesentery, while no apparent primary lesion is detected in the parenchymal organs. In most cases, the lesions are multifocal, and some patients might present with single nodular lesions. In some cases, paravertebral involvement is also visible. Even the peritoneum may be thickened in a diffuse and nodular manner, similar to that of mesothelioma. In other cases, liver metastases occur, accompanied by ascites. Diagnosis only through noninvasive imaging examinations is difficult.

In the present study, ultrasound examination detected cystic-solid masses, suggesting the occurrence of necrosis and hemorrhage. Abdominal ultrasonography findings were also highly suspicious and suggested a multifocal cystic-solid mass in the abdominal or pelvic cavity and other large organs consistent for the presentation of DSRCT. A definitive diagnosis is only obtained based on pathological findings.

Current therapies are mainly dependent on surgical resection, chemotherapy, and radiotherapy. According to the patient’s condition, interventional therapy can be given, and preoperatively induced chemotherapy, surgery, and radiotherapy. Recent studies show that complete surgical excision, including a 1 to 2 mm- long implant, is necessary to achieve long-term disease control. Intraperitoneal hyperthermic chemotherapy using cisplatin is thought to be effective at reducing the recurrence rate of disease [12]. Nevertheless, patients presenting with DSRCT have a poor prognosis, with only a 29% actuarial three-year survival rate and an 18% five-year survival rate [13, 14].

Conclusion

DSRCT is a rare malignant tumor with a poor prognosis, and it mainly affects young males. Imaging examination alone is not sufficient for a definitive diagnosis, and immunohistochemistry and cytogenetic studies are suggested.

Declarations

Authors’ Affiliations

(1)
Department of Ultrasound, Affiliated Hospital of Medical College Qingdao University
(2)
Department of Pathology, Affiliated Hospital of Medical College Qingdao University

References

  1. Gerald WL, Rosai J: Case 2. Desmoplastic small cell tumor with divergent differentiation. Pediatr Pathol. 1989, 9: 177-183. 10.3109/15513818909022347.View ArticlePubMedGoogle Scholar
  2. Gerald WL, Miller HK, Battifora H, Miettinen M, Silva EG, Rosai J: Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol. 1991, 15: 499-513. 10.1097/00000478-199106000-00001.View ArticlePubMedGoogle Scholar
  3. Zhu ZX, Wang J: Softtissue tumor pathology. 2008, Beijing: People's Medical Publishing HouseGoogle Scholar
  4. Amato RJ, Ellerhorst JA, Ayala AG: Intraabdominal desmoplastic small cell tumor. Report and discussion of five cases. Cancer. 1996, 78: 845-851. 10.1002/(SICI)1097-0142(19960815)78:4<845::AID-CNCR22>3.0.CO;2-U.View ArticlePubMedGoogle Scholar
  5. Hassan I, Shyyan R, Donohue JH, Edmonson JH, Gunderson LL, Moir CR, Arndt CA, Nascimento AG, Que FG: Intraabdominal desmoplastic small round cell tumors: a diagnostic and therapeutic challenge. Cancer. 2005, 104: 1264-1270. 10.1002/cncr.21282.View ArticlePubMedGoogle Scholar
  6. Barnoud R, Sabourin JC, Pasquier D, Ranchere D, Bailly C, Terrier-Lacombe MJ, Pasquier B: Immunohistochemical expression of WT1 by desmoplastic small round cell tumor: a comparative study with other small round cell tumors. Am J Surg Pathol. 2000, 24: 830-836. 10.1097/00000478-200006000-00008.View ArticlePubMedGoogle Scholar
  7. Gerald WL, Ladanyi M, de Alava E, Cuatrecasas M, Kushner BH, LaQuaglia MP, Rosai J: Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol. 1998, 16: 3028-3036.PubMedGoogle Scholar
  8. Yang JL, Xu WP, Wang J, Zhu XZ, Zhang RY: [Desmoplastic small round cell tumor: a clinicopathologic study of 15 cases]. Zhonghua Bing Li Xue Za Zhi. 2005, 34: 650-655.PubMedGoogle Scholar
  9. Cummings OW, Ulbright TM, Young RH, Dei Tos AP, Fletcher CD, Hull MT: Desmoplastic small round cell tumors of the paratesticular region. A report of six cases. Am J Surg Pathol. 1997, 21: 219-225. 10.1097/00000478-199702000-00013.View ArticlePubMedGoogle Scholar
  10. Bismar TA, Basturk O, Gerald WL, Schwarz K, Adsay NV: Desmoplastic small cell tumor in the pancreas. Am J Surg Pathol. 2004, 28: 808-812. 10.1097/01.pas.0000126782.94781.dc.View ArticlePubMedGoogle Scholar
  11. Adsay V, Cheng J, Athanasian E, Gerald W, Rosai J: Primary desmoplastic small cell tumor of soft tissues and bone of the hand. Am J Surg Pathol. 1999, 23: 1408-1413. 10.1097/00000478-199911000-00012.View ArticlePubMedGoogle Scholar
  12. Hayes-Jordan A, Anderson PM: The diagnosis and management of desmoplastic small round cell tumor: a review. Curr Opin Oncol. 2011, 23: 385-389. 10.1097/CCO.0b013e3283477aab.View ArticlePubMedGoogle Scholar
  13. Mingo L, Seguel F, Rollan V: Intraabdominal desmoplastic small round cell tumour. Pediatr Surg Int. 2005, 21: 279-281. 10.1007/s00383-005-1401-1.View ArticlePubMedGoogle Scholar
  14. Kushner BH, LaQuaglia MP, Wollner N, Meyers PA, Lindsley KL, Ghavimi F, Merchant TE, Boulad F, Cheung NK, Bonilla MA, Crouch G, Kelleher JF, Steinherz PG, Gerald WL: Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol. 1996, 14: 1526-1531.PubMedGoogle Scholar

Copyright

© Li et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement